Amneal Pharmaceuticals Overview
Amneal Pharmaceuticals Target Price
Analysts' 12-month price predictions for AMRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$16.66
Average Target Price
$17.33
4% upside
4% upside3 analysts in the last 4 months
High: $19 | Low: $16
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-20 | BarclaysGlen Santangelo | $16 |  4% downside |  |
| 2026-04-17 | UBSAshwani Verma | $19 | 14% upside | |
| 2026-03-02 | Truist FinancialLes Sulewski | $17 | 2% upside | |
| 2026-01-07 | Truist Financial | $15 | 10% downside | |
| 2025-12-08 | Barclays | $15 | 10% downside | |
| 2025-03-03 | Barclays | $11 | 34% downside | |
| 2024-11-11 | Piper SandlerDavid Amsellem | $11 | 34% downside | |
| 2024-10-02 | Truist FinancialLes Sulewski | $12 | 28% downside | |
| 2024-10-01 | Truist FinancialLes Sulewski | $10 | 40% downside | |
| 2024-05-03 | Truist FinancialLes Sulewski | $9 | 46% downside | |
| 2024-03-21 | Piper SandlerDavid Amsellem | $8 | 52% downside | |
| 2022-08-08 | Goldman Sachs | $4 | 76% downside | |